Andrew Numedahl

Senior Pricing Analyst at Prime Therapeutics

Andrew Numedahl is a seasoned financial professional with extensive experience in pricing analysis and financial management. Currently serving as a Senior Pricing Analyst at Prime Therapeutics since May 2022, Andrew previously held prominent roles including Senior Financial Analyst at PreferredOne from May 2014 to June 2022, and Senior Revenue Accountant at UnitedHealthcare from December 2008 to May 2014. Andrew began their career as a Staff Accountant at Carlson Companies in 2008. Andrew holds a degree from Luther College, where studies were completed from 2003 to 2007.

Links


Org chart